Yongheng Shu

Targeting tumor-associated macrophages for cancer immunotherapy.

P. Cheng, Yongheng Shu, 2020, Biochimica et biophysica acta. Reviews on cancer.

The Effect of Residual Triton X-100 on Structural Stability and Infection Activity of Adenovirus Particles

P. Cheng, Bin Zhang, C. Su, 2020, Molecular therapy. Methods & clinical development.

A novel method to purify adenovirus based on increasing salt concentrations in buffer.

Yuquan Wei, Yuhua Li, P. Cheng, 2019, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

In Situ Tumor Vaccine Expressing Anti-CD47 Antibody Enhances Antitumor Immunity

Pi-Yun Cheng, Yongheng Shu, Jinhu Ma, 2022, Frontiers in Oncology.

Antifibrotic therapy augments the antitumor effects of vesicular stomatitis virus via reprogramming tumor microenvironment.

Pi-Yun Cheng, Yongheng Shu, Bin Zhang, 2021, Human gene therapy.

Engineered exosome-like nanovesicles suppress tumor growth by reprogramming tumor microenvironment and promoting tumor ferroptosis.

P. Cheng, Anliang Huang, Yan Zhang, 2021, Acta biomaterialia.

Live-attenuated Japanese encephalitis virus inhibits glioblastoma growth and elicits potent antitumor immunity

Pi-Yun Cheng, Jing Zhao, Yuhua Li, 2023, Frontiers in Immunology.

Long noncoding RNA RP11-241J12.3 targeting pyruvate carboxylase promotes hepatocellular carcinoma aggressiveness by disrupting pyruvate metabolism and the DNA mismatch repair system

Pi-Yun Cheng, Yan Zhang, Bin Zhang, 2022, Molecular Biomedicine.

High-dose vitamin C synergizes with oncolytic adenoviruses against tumor by enhancing immunogenic tumor cell death and reprogramming tumor immune microenvironment.

H. Deng, P. Cheng, Anliang Huang, 2021, Molecular therapy : the journal of the American Society of Gene Therapy.